Regen Biopharma's total assets for Q1 2025 were $196.78K, an increase of 10.80% from the previous quarter. RGBP total liabilities were $5.80M for the fiscal quarter, a 7.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.